ELEVATE, a global observational longitudinal prospective registry of patients with acute hepatic porphyria (AHP)

Project: Other project

Project Details

StatusActive
Effective start/end date8/20/21 → 8/19/26

Funding

  • Alnylam Pharmaceuticals, Inc: $12,200.00